CAPR - Company ID 0001133869
The table below shows CAPRICOR THERAPEUTICS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $287.85M | $11.29M | $14.69M | $9.60M | $34.89M | $32.67M |
| Short-term investments | - | $140.23M | $24.79M | $31.82M | - | $5.99M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $322.94M |
| $163.39M |
| $50.86M |
| $42.89M |
| $36.44M |
| $33.68M |
| Property, plant & equipment | $18.31M | $5.56M | $5.56M | $4.59M | $1.80M | $850.85K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $355.95M | $170.48M | $58.73M | $50.09M | $41.33M | $34.62M |
| Accounts payable | $1.65M | - | - | - | - | - |
| Total current liabilities | $35.84M | $21.03M | $31.27M | $23.59M | $4.13M | $2.97M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $50.16M | $25.02M | $36.13M | $38.31M | $9.96M | $6.42M |
| Retained earnings | -$304.88M | -$199.83M | -$159.37M | -$137.08M | -$108.06M | -$88.04M |
| Total equity | $305.79M | $145.46M | $22.60M | $11.79M | $31.37M | $28.20M |